Mitsuhiro Goda
Papers
1
Total Citations
17
H-Index
1
About
Mitsuhiro Goda is a leading pharmacovigilance researcher whose work centers on the safety profiles of oncological therapies, with a particular focus on prostate cancer treatment. His research critically examines the real-world adverse effects of antiandrogen drugs, a cornerstone of prostate cancer management. In his most cited work, Goda conducted a comprehensive analysis of spontaneous adverse effect databases to evaluate the potential complications of interstitial lung disease (ILD) associated with antiandrogen use. This study, which has garnered 17 citations, is notable for its large-scale, data-driven approach, analyzing global trends from 2002 to 2018—a period during which prostate cancer cases worldwide surged from approximately 679,000 to over 1.27 million. By identifying and characterizing ILD risks linked to these therapies, Goda’s contribution provides critical safety insights for clinicians navigating treatment options like total prostatectomy, radiation, and pharmacological interventions. His work exemplifies the vital intersection of clinical oncology and pharmacoepidemiology, helping to balance therapeutic efficacy with patient safety. Through his meticulous database analyses, Goda has established himself as a key voice in ensuring that the expanding arsenal of cancer treatments is used with a full understanding of their potential harms.
Research Focus
Key Achievements
Top Papers
- 1